Literature DB >> 26579341

Beautif(o)ul.

Georgia-Alexandra Spyropoulou1, Leonidas Pavlidis1, Alexander Dionyssopoulos1.   

Abstract

Entities:  

Year:  2015        PMID: 26579341      PMCID: PMC4634172          DOI: 10.1097/GOX.0000000000000508

Source DB:  PubMed          Journal:  Plast Reconstr Surg Glob Open        ISSN: 2169-7574


× No keyword cloud information.

Sir:

Duck face, sleek foreheads with eyebrows ptosed and far apart from each other, prominent cheek bones, excessive sized breasts. Women may after several aesthetic operations start to look alike.[1,2] We all see these signs in people of showbiz and around us and they all do not suffer from body dysmorphic disorder.[3] Although “beauty is in the eye of the beholder,” we would like to express our concern on the responsibility of the plastic surgeon and how we advise our patients who seek aesthetic surgery procedures. According to our opinion, there are specific issues to be addressed: If a patient asks for surgery that is legal but not ethical, should we operate? What is the limit after which a surgeon should refuse another plastic surgery procedure to a patient? Should we try to persuade the patient to have procedures that will improve his/her appearance but without giving him/her an operated/artificial look? We would be interested in hearing a consensus of leading aesthetic surgeons on these subjects.

DISCLOSURE

The authors have no financial interest to declare in relation to the content of this article. The Article Processing Charge was paid for by the authors.
  3 in total

1.  The perception of beauty after facial plastic surgery.

Authors:  Samuel M Lam
Journal:  JAMA Facial Plast Surg       Date:  2015 May-Jun       Impact factor: 4.611

2.  The new criteria for body dysmorphic disorder: who makes the diagnosis?

Authors:  Mark B Constantian
Journal:  Plast Reconstr Surg       Date:  2013-12       Impact factor: 4.730

3.  Facial cosmetic surgery: a 30-year perspective.

Authors:  I Pitanguy
Journal:  Plast Reconstr Surg       Date:  2000-04       Impact factor: 4.730

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.